What is Bed Bath & Beyond, Inc.'s earnings per share (EPS)?

Bed Bath & Beyond, Inc. (BBBY) reported diluted earnings per share of -$1.41 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Bed Bath & Beyond (BBBY) Financials

BBBY NYSE

Trailing 12 months to June 30, 2026

Revenue $1.1B +1.0% YoY

Net Income -$81.3M n/m YoY

EPS (Diluted) -$1.14 YoY not available

Free Cash Flow -$80.7M n/m YoY

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 4, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BBBY SEC filings page.

Bed Bath & Beyond, Inc. (BBBY) reported $1.1B in revenue over the twelve months to Jun 30, 2026, up 1.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BBBY FY2025 2026-10-25

Sales are shrinking, but cost cuts have narrowed losses while financing inflows, not operations, supplied cash in FY2025.

Gross margin reached 24.6% even as revenue fell 25.1%, while SG&A declined 28.0%; this is margin repair during contraction, not operating leverage from growth. The improvement in reported profitability therefore did not yet translate into self-funding operations.

Operating loss narrowed to $61.2M, but operating cash flow remained negative at -$56.7M; with capital expenditures of only $7.4M, the cash shortfall was primarily operational rather than a heavy reinvestment burden. Accounting improvement still trails cash generation.

Debt was $0, liabilities fell 13.2%, and equity rose 33.7% alongside financing cash flow of $122.1M, making the balance-sheet improvement closely associated with financing activity. Meanwhile, receivables rose 31.4% as revenue fell, while inventory dropped 55.3%, shifting working capital toward amounts still to be collected.

Financial Health Signals

Financial Health Score 29/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Bed Bath & Beyond, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Bed Bath & Beyond, Inc. has an operating margin of -5.9%, meaning the company loses $6 on every $100 of revenue. This results in a profitability score of 21/100. This is up from -13.2% the prior year.

Growth

Bed Bath & Beyond, Inc.'s revenue declined 25.1% year-over-year, from $1.4B to $1.0B. This contraction results in a growth score of 5/100.

Leverage

Bed Bath & Beyond, Inc. carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 89/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Bed Bath & Beyond, Inc.'s current ratio of 1.25 indicates adequate short-term liquidity, earning a score of 32/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Bed Bath & Beyond, Inc.'s operations used $56.7M of cash, and capex of $7.4M added to the outflow, for a free cash flow shortfall of $64.1M. This results in a cash flow score of 14/100.

Returns

Bed Bath & Beyond, Inc. posts a -38.9% return on equity (ROE), meaning it loses $39 for every $100 of shareholders' equity. This results in a returns score of 11/100. This is up from -159.0% the prior year.

Piotroski F-Score Partial

4/8

Bed Bath & Beyond, Inc. passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.

Earnings Quality No Cash Backing

N/A

Bed Bath & Beyond, Inc. reported a net loss of $84.6M while operations used $56.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Bed Bath & Beyond, Inc. reported an operating loss of $61.2M against $1.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$361.2M

YoY+28.0%

QoQ+45.8%

5Y CAGR-14.6%

10Y CAGR-1.5%

Bed Bath & Beyond, Inc. generated $361.2M in revenue in Q2 2026. This represents an increase of 28.0% from the same quarter a year earlier. Against the prior quarter it is up 45.8%.

EBITDA

-$34.8M

YoYn/m

QoQn/m

Bed Bath & Beyond, Inc.'s EBITDA was -$34.8M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income

-$39.5M

YoYn/m

QoQn/m

10Y CAGRn/m

Bed Bath & Beyond, Inc. reported a net loss of $39.5M in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)

-$0.53

YoYn/m

QoQn/m

10Y CAGRn/m

Bed Bath & Beyond, Inc. earned -$0.53 per diluted share (EPS) in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Balance Sheet

Free Cash Flow

-$41.9M

YoY-398.7%

QoQn/m

10Y CAGRn/m

Bed Bath & Beyond, Inc. recorded an outflow of $41.9M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 398.7% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt

$99.5M

YoY-17.5%

QoQ-26.8%

5Y CAGR-28.6%

10Y CAGR-2.1%

Bed Bath & Beyond, Inc. held $99.5M in cash against $13.5M in long-term debt as of Q2 2026, with $312.2M of liabilities due within a year.

Shares Outstanding

95M

YoY+66.1%

QoQ+28.9%

5Y CAGR+17.3%

10Y CAGR+14.2%

Bed Bath & Beyond, Inc. had 95M shares outstanding in Q2 2026. This represents an increase of 66.1% from the same quarter a year earlier. Against the prior quarter it is up 28.9%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

26.8%

YoY+3.0pp

QoQ+2.9pp

5Y change+4.8pp

10Y change+8.5pp

Bed Bath & Beyond, Inc.'s gross margin was 26.8% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 3.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.9 percentage points.

Operating Margin

-11.9%

YoY-7.5pp

QoQ-4.5pp

5Y change-16.5pp

10Y change-10.5pp

Bed Bath & Beyond, Inc.'s operating margin was -11.9% in Q2 2026, reflecting core business profitability. This is down 7.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.5 percentage points.

Net Margin

-10.9%

YoY-4.1pp

QoQ-4.3pp

5Y change-50.0pp

10Y change-10.7pp

Bed Bath & Beyond, Inc.'s net profit margin was -10.9% in Q2 2026, showing the share of revenue converted to profit. This is down 4.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.3 percentage points.

Return on Equity

-18.4%

YoY-3.6pp

QoQ-10.3pp

5Y change-64.2pp

10Y change-17.8pp

Bed Bath & Beyond, Inc.'s quarterly ROE was -18.4% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is down 3.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 10.3 percentage points.

Capital Allocation

Capital Expenditures

$3.6M

YoY+99.8%

QoQ+252.7%

5Y CAGR+2.3%

10Y CAGR-17.0%

Bed Bath & Beyond, Inc. invested $3.6M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 99.8% from the same quarter a year earlier. Against the prior quarter it is up 252.7%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

BBBY Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BBBY quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$1.1B	$1.0B-25.1%	$1.4B-10.6%	$1.6B-19.1%	$1.9B-30.0%	$2.8B+10.5%	$2.5B+73.8%	$1.4B-21.2%	$1.8B+4.4%	$1.7B-3.1%	$1.8B+8.6%	$1.7B+10.7%	$1.5B+14.8%	$1.3B+18.6%	$1.1B+4.3%	$1.1B
Cost of Revenue	$851.2M	$787.1M-28.8%	$1.1B-7.6%	$1.2B-15.9%	$1.4B-33.3%	$2.1B+10.9%	$1.9B+67.6%	$1.1B-21.8%	$1.5B+4.5%	$1.4B-4.4%	$1.5B+8.5%	$1.4B+11.1%	$1.2B+15.3%	$1.1B+17.3%	$900.9M+2.9%	$875.2M
Gross Profit	$288.3M	$257.5M-11.2%	$290.2M-20.7%	$366.0M-27.9%	$507.6M-18.6%	$623.9M+9.2%	$571.4M+98.4%	$287.9M-18.6%	$353.9M+3.9%	$340.6M+2.8%	$331.3M+8.8%	$304.7M+9.2%	$279.1M+12.7%	$247.7M+24.8%	$198.4M+10.8%	$179.1M
SG&A Expenses	$97.6M	$53.6M-28.0%	$74.4M-17.7%	$90.4M+13.4%	$79.7M-8.8%	$87.4M-10.5%	$97.7M+1.0%	$96.7M-41.2%	$164.5M+81.3%	$90.7M+1.6%	$89.3M+8.7%	$82.2M+14.5%	$71.8M+5.3%	$68.2M+19.1%	$57.3M-15.5%	$67.8M
Operating Income	-$86.7M	-$61.2Mn/m	-$184.1Mn/m	-$144.0M-633.1%	$27.0M-75.7%	$111.1M+14.8%	$96.7Mn/m	-$62.4Mn/m	-$217.2Mn/m	-$46.6M-774.4%	$6.9Mn/m	-$534K-104.5%	$11.9M-28.0%	$16.6M+36.2%	$12.2Mn/m	-$17.5M
EBITDA	N/A	-$44.9Mn/m	-$165.0Mn/m	-$124.5M-384.9%	$43.7M-66.3%	$129.6M+9.4%	$118.5Mn/m	-$36.9Mn/m	-$185.5Mn/m	-$13.8M-140.3%	$34.2M+48.8%	$23.0M-23.1%	$29.9M-3.6%	$31.0M+10.0%	$28.2Mn/m	-$1.2M
Interest Expense	$2.0M	$1.2M-46.7%	$2.2M+25.0%	$1.8M-9.1%	$1.9M-7.0%	$2.1M+5.7%	$2.0M+476.3%	$342K-76.7%	$1.5M-50.0%	$2.9M+234.9%	$877K+526.4%	$140K+259.0%	$39K-65.5%	$113K-86.0%	$809K-67.4%	$2.5M
Income Tax	-$1.9M	$825K+20.6%	$684K-98.4%	$41.7M+2914.5%	$1.4Mn/m	-$48.8M-3678.5%	$1.4M+28.6%	$1.1Mn/m	-$2.4M-103.7%	$64.2M+590.4%	$9.3M+390.6%	$1.9M-57.0%	$4.4Mn/m	-$68.0M-14127.6%	$485Kn/m	-$142K
Net Income	-$81.3M	-$84.6Mn/m	-$258.8Mn/m	-$307.8Mn/m	-$35.2M-109.0%	$389.4M+595.3%	$56.0Mn/m	-$121.8Mn/m	-$206.1Mn/m	-$109.9M-977.5%	$12.5M+411.9%	$2.4M-72.4%	$8.9M-89.5%	$84.4M+475.2%	$14.7Mn/m	-$19.4M
EPS (Basic)	N/A	-$1.41n/m	-$5.56n/m	-$6.81n/m	-$0.83-110.1%	$8.18+554.4%	$1.25n/m	-$3.46n/m	-$6.83n/m	-$4.28-973.5%	$0.49+390.0%	$0.10-73.0%	$0.37-89.6%	$3.56+465.1%	$0.63n/m	-$0.84
EPS (Diluted)	-$1.14	-$1.41n/m	-$5.56n/m	-$6.81n/m	-$0.83-110.2%	$8.11+554.0%	$1.24n/m	-$3.46n/m	-$6.83n/m	-$4.28-973.5%	$0.49+390.0%	$0.10-72.2%	$0.36-89.6%	$3.47+459.7%	$0.62n/m	-$0.84
Diluted Shares (Avg)	N/A	60M+29.2%	47M+2.9%	45M+2.0%	44M+2.3%	43M+4.1%	42M+19.3%	35M+16.3%	30M+19.7%	25M-1.5%	25M+2.9%	25M+1.6%	24M+0.1%	24M+2.6%	24M+1.8%	23M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$361.2M+28.0%	$247.8M+6.9%	$273.4M-9.8%	$257.2M-17.4%	$282.3M-29.1%	$231.7M-39.4%	$303.2M-21.1%	$311.4M-16.6%
Cost of Revenue	$264.5M+22.9%	$188.6M+8.6%	$206.2M-11.7%	$192.0M-21.8%	$215.3M-32.3%	$173.6M-43.6%	$233.5M-24.8%	$245.5M-15.5%
Gross Profit	$96.7M+44.4%	$59.2M+1.8%	$67.3M-3.5%	$65.2M-1.2%	$67.0M-16.5%	$58.1M-21.8%	$69.7M-5.7%	$66.0M-20.4%
SG&A Expenses	$57.5M+308.3%	$14.9M+3.8%	$13.2M-26.0%	$12.0M-31.9%	$14.1M-24.0%	$14.3M-30.0%	$17.8M-26.1%	$17.6M-27.1%
Operating Income	-$42.9Mn/m	-$18.2Mn/m	-$13.1Mn/m	-$12.5Mn/m	-$12.4Mn/m	-$23.2Mn/m	-$34.4Mn/m	-$45.2Mn/m
EBITDA	-$34.8Mn/m	-$15.0Mn/m	-$9.3Mn/m	-$8.8Mn/m	-$8.5Mn/m	-$18.4Mn/m	-$27.5Mn/m	-$41.1Mn/m
Interest Expense	$750K-15.6%	$1.7M+126.9%	-$1.7Mn/m	$1.2M-23.7%	$889K-61.5%	$762K-72.0%	-$4.4Mn/m	$1.6M-51.5%
Income Tax	-$2.5M-976.7%	$249K+28.4%	$111K+126.5%	$233K+23.3%	$287K+145.3%	$194K-41.0%	$49K-99.9%	$189Kn/m
Net Income	-$39.5Mn/m	-$16.4Mn/m	-$20.9Mn/m	-$4.5Mn/m	-$19.3Mn/m	-$39.9Mn/m	-$81.3Mn/m	-$61.0Mn/m
EPS (Basic)	-$0.53n/m	-$0.24n/m	-$0.30n/m	-$0.07n/m	-$0.34n/m	-$0.74n/m	-$1.68n/m	-$1.33n/m
EPS (Diluted)	-$0.53n/m	-$0.24n/m	-$0.30n/m	-$0.07n/m	-$0.34n/m	-$0.74n/m	-$1.68n/m	-$1.33n/m
Diluted Shares (Avg)	74M+29.2%	69M+28.7%	N/A	60M+31.8%	58M+25.7%	54M+17.7%	N/A	46M+1.2%

Not reported in any period shown, so not listed: R&D Expenses.

BBBY Balance Sheet

BBBY quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$425.5M+5.9%	$402.0M-36.8%	$635.8M-27.6%	$878.5M-17.6%	$1.1B+28.4%	$830.2M+98.7%	$417.7M-9.4%	$461.2M+6.3%	$433.8M-10.6%	$485.1M+13.2%	$428.4M+13.7%	$376.9M+19.4%	$315.6M+73.4%	$182.0M+1.4%	$179.6M
Current Assets	$240.1M+5.5%	$227.5M-35.0%	$350.1M-15.5%	$414.5M-24.9%	$551.8M-5.3%	$582.7M+228.6%	$177.4M-17.6%	$215.3M-18.8%	$265.2M+8.5%	$244.4M-1.6%	$248.4M-3.8%	$258.1M+17.8%	$219.0M+40.4%	$156.0M+4.6%	$149.2M
Cash & Equivalents	$175.3M+10.1%	$159.2M-47.4%	$302.6M-18.5%	$371.3M-26.2%	$503.3M+1.6%	$495.4M+341.3%	$112.3M-20.7%	$141.5M-30.4%	$203.2M+11.0%	$183.1M+7.5%	$170.3M-6.3%	$181.6M+22.2%	$148.7M+58.9%	$93.5M-3.5%	$97.0M
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0-100.0%	$1.8M-82.9%	$10.3Mn/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Inventory	$5.2M-55.3%	$11.5M-11.5%	$13.0M+99.8%	$6.5M+27.0%	$5.1M-17.7%	$6.2M+6.9%	$5.8M-58.6%	$14.1M+3.0%	$13.7M-27.6%	$18.9M-5.5%	$20.0M-23.5%	$26.2M-3.1%	$27.0M+2.2%	$26.5M+15.1%	$23.0M
Accounts Receivable	$20.8M+31.4%	$15.8M-18.4%	$19.4M+9.8%	$17.7M-16.5%	$21.2M-7.3%	$22.9M-7.5%	$24.7M-31.2%	$35.9M+19.4%	$30.1M+6.9%	$28.1M+74.5%	$16.1M-15.0%	$19.0M+18.2%	$16.0M-16.7%	$19.3M+42.8%	$13.5M
Long-Term Investments	$66.6M-14.8%	$78.2M-49.8%	$155.9M-47.4%	$296.3M-13.5%	$342.7M+9161.7%	$3.7M-5.1%	$3.9M-78.0%	$17.7M+172.3%	$6.5M-44.7%	$11.8Mn/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Goodwill	$6.2M0.0%	$6.2M0.0%	$6.2M0.0%	$6.2M0.0%	$6.2M0.0%	$6.2M-77.3%	$27.1M+18.5%	$22.9M+55.8%	$14.7M0.0%	$14.7M-4.5%	$15.4M+452.7%	$2.8M0.0%	$2.8M0.0%	$2.8M0.0%	$2.8M
Total Liabilities	$207.5M-13.2%	$239.2M-13.5%	$276.7M+18.9%	$232.7M-27.6%	$321.6M-18.4%	$393.9M+64.2%	$239.9M-4.2%	$250.5M-4.3%	$261.7M-16.2%	$312.1M+11.9%	$279.0M+12.7%	$247.6M+25.8%	$196.9M+30.4%	$151.0M-9.2%	$166.3M
Current Liabilities	$192.1M-14.5%	$224.9M-3.2%	$232.4M+21.6%	$191.1M-29.8%	$272.3M-16.9%	$327.6M+51.7%	$216.0M-10.6%	$241.5M+12.5%	$214.7M-13.9%	$249.2M-3.7%	$258.7M+6.5%	$242.8M+25.4%	$193.6M+30.4%	$148.5M-9.1%	$163.3M
Non-Current Liabilities	$15.4M+7.2%	$14.4M-67.6%	$44.3M+6.5%	$41.6M-15.6%	$49.2M-25.7%	$66.3M+177.7%	$23.9M+164.5%	$9.0M-80.8%	$47.0M-25.2%	$62.9M+209.1%	$20.4M+320.2%	$4.8M+47.0%	$3.3M+30.6%	$2.5M-15.9%	$3.0M
Long-Term Debt	$0	N/A	N/A	$34.5M-9.2%	$38.0M-8.1%	$41.3Mn/m	$0-100.0%	$3.1Mn/m	$0-100.0%	$44.2M+399.6%	$8.8Mn/m	$0	N/A	N/A	N/A
Total Equity	$217.6M+33.7%	$162.7M-54.7%	$359.1M-44.4%	$645.8M-13.2%	$744.4M+99.2%	$373.7M+224.7%	$115.1M-12.6%	$131.7M-25.0%	$175.6M+0.2%	$175.3M+16.5%	$150.5M+16.4%	$129.2M+8.8%	$118.8M+283.6%	$31.0M+133.9%	$13.2M
Retained Earnings	-$842.7Mn/m	-$740.5Mn/m	-$481.7Mn/m	-$173.8Mn/m	-$136.6Mn/m	-$525.2Mn/m	-$580.4Mn/m	-$458.9Mn/m	-$254.7Mn/m	-$153.9Mn/m	-$166.4Mn/m	-$153.9Mn/m	-$162.7Mn/m	-$247.1Mn/m	-$261.8M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$634.2M+77.1%	$404.5M+11.2%	$425.5M+5.9%	$414.4M-3.3%	$358.1M-27.9%	$363.7M-37.0%	$402.0M-36.8%	$428.3M-44.4%
Current Assets	$237.4M+21.2%	$196.7M+0.1%	$240.1M+5.5%	$231.8M+26.6%	$195.9M-15.7%	$196.5M-35.7%	$227.5M-35.0%	$183.1M-51.3%
Cash & Equivalents	$99.5M-17.5%	$135.8M+18.5%	$175.3M+10.1%	$167.4M+19.2%	$120.6M-35.2%	$114.6M-55.3%	$159.2M-47.4%	$140.4M-56.9%
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Inventory	$52.2M+520.2%	$496K-98.0%	$5.2M-55.3%	$7.2M-34.8%	$8.4M-30.5%	$24.6M+90.6%	$11.5M-11.5%	$11.1M-4.0%
Accounts Receivable	$29.8M+27.6%	$24.0M+32.8%	$20.8M+31.4%	$17.3M+15.2%	$23.3M+24.9%	$18.1M-21.7%	$15.8M-18.4%	$15.0M-23.3%
Long-Term Investments	$55.9M-21.9%	$64.2M-17.4%	$66.6M-14.8%	$78.6M-30.1%	$71.6M-44.8%	$77.7M-43.4%	$78.2M-49.8%	$112.5M-33.6%
Goodwill	$101.9M+1555.0%	$6.2M0.0%	$6.2M0.0%	$6.2M0.0%	$6.2M0.0%	$6.2M0.0%	$6.2M0.0%	$6.2M0.0%
Total Liabilities	$419.1M+84.7%	$202.0M-8.3%	$207.5M-13.2%	$211.4M-8.9%	$226.9M-7.9%	$220.4M-23.9%	$239.2M-13.5%	$232.1M-8.8%
Current Liabilities	$312.2M+44.9%	$190.1M-7.8%	$192.1M-14.5%	$197.8M+4.6%	$215.4M+6.1%	$206.1M-16.2%	$224.9M-3.2%	$189.0M-9.7%
Non-Current Liabilities	$106.9M+835.3%	$11.9M-16.2%	$15.4M+7.2%	$13.6M-68.3%	$11.4M-73.7%	$14.2M-67.4%	$14.4M-67.6%	$43.1M-4.7%
Long-Term Debt	$13.5M	N/A	$0	N/A	N/A	N/A	N/A	N/A
Total Equity	$214.8M+64.1%	$202.1M+41.0%	$217.6M+33.7%	$202.6M+3.3%	$130.9M-47.7%	$143.4M-50.2%	$162.7M-54.7%	$196.2M-62.0%
Retained Earnings	-$898.6Mn/m	-$859.1Mn/m	-$842.7Mn/m	-$804.2Mn/m	-$799.7Mn/m	-$780.4Mn/m	-$740.5Mn/m	-$659.2Mn/m

BBBY Cash Flow Statement

BBBY quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$71.6M	-$56.7Mn/m	-$174.3Mn/m	-$18.6Mn/m	-$12.5M-115.5%	$80.9M-58.8%	$196.5Mn/m	-$81.6Mn/m	-$138.9Mn/m	-$35.2M-189.0%	$39.6M-27.4%	$54.5M-32.6%	$80.8M-3.4%	$83.6M+197.2%	$28.1M+9.7%	$25.7M
Depreciation & Amortization	N/A	$16.3M-14.6%	$19.1M-2.0%	$19.4M+16.4%	$16.7M-10.0%	$18.6M-14.8%	$21.8M-14.7%	$25.5M-19.5%	$31.7M-3.5%	$32.8M+20.4%	$27.3M+16.0%	$23.5M+30.9%	$18.0M+24.4%	$14.4M-9.8%	$16.0M-2.1%	$16.4M
Stock-Based Compensation	N/A	$10.9M-43.6%	$19.3M-16.3%	$23.0M+25.7%	$18.3M+64.5%	$11.1M+42.0%	$7.8M-51.5%	$16.2M+12.6%	$14.4M+252.1%	$4.1M-16.6%	$4.9M+38.7%	$3.5M-12.6%	$4.0M+24.1%	$3.3M-7.8%	$3.5M+15.6%	$3.1M
Capital Expenditures	$9.1M	$7.4M-48.3%	$14.3M-25.4%	$19.2M+28.7%	$14.9M+9.4%	$13.6M-8.5%	$14.9M+15.9%	$12.8M-55.2%	$28.7M+21.6%	$23.6M-67.4%	$72.3M+21.5%	$59.5M+43.9%	$41.3M+128.8%	$18.1M+44.7%	$12.5M+42.9%	$8.7M
Free Cash Flow	-$80.7M	-$64.1Mn/m	-$188.6Mn/m	-$37.8Mn/m	-$27.4M-140.8%	$67.3M-62.9%	$181.6Mn/m	-$94.4Mn/m	-$167.6Mn/m	-$58.8Mn/m	-$32.7Mn/m	-$5.0M-112.7%	$39.5M-39.8%	$65.6M+318.9%	$15.7M-7.5%	$16.9M
Investing Cash Flow	-$68.5M	-$49.2M-297.5%	$24.9Mn/m	-$44.6Mn/m	-$33.0Mn/m	-$86.1Mn/m	-$23.6Mn/m	-$26.9Mn/m	-$110.9Mn/m	-$18.0Mn/m	-$79.4Mn/m	-$82.4M	N/A	N/A	N/A	N/A
Financing Cash Flow	$119.0M	$122.1M+273.0%	$32.7Mn/m	-$5.5Mn/m	-$86.3Mn/m	-$10.6M-104.6%	$231.4M+187.2%	$80.5M-57.4%	$189.0M+157.8%	$73.3M+39.1%	$52.7M+218.8%	$16.5M	N/A	N/A	N/A	N/A
Share Buybacks	N/A	$6.2Mn/m	$0n/m	$0-100.0%	$80.1Mn/m	$0n/m	$0n/m	$0n/m	$0-100.0%	$10.0Mn/m	$0-100.0%	$2.4M+2.9%	$2.3M+65.4%	$1.4M+195.3%	$471K-70.6%	$1.6M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$38.2M-341.6%	-$11.8Mn/m	-$6.5Mn/m	-$15.1Mn/m	$15.8Mn/m	-$50.9Mn/m	-$21.7Mn/m	-$42.1Mn/m
Depreciation & Amortization	$8.1M+109.1%	$3.2M-33.9%	$3.5M-45.0%	$3.7M-10.4%	$3.9M-6.1%	$4.8M+22.3%	$6.3M+36.7%	$4.1M+1.7%
Stock-Based Compensation	$2.1M-38.7%	$1.5M+40.1%	N/A	$3.5M-44.5%	$3.4M-35.6%	$1.1M-77.1%	N/A	$6.3M+9.5%
Capital Expenditures	$3.6M+99.8%	$1.0M-13.0%	$2.2M-27.7%	$2.3M-33.2%	$1.8M-60.0%	$1.2M-65.5%	$3.0M+13.2%	$3.4M-24.8%
Free Cash Flow	-$41.9M-398.7%	-$12.8Mn/m	-$8.6Mn/m	-$17.4Mn/m	$14.0Mn/m	-$52.1Mn/m	-$24.7Mn/m	-$45.5Mn/m
Investing Cash Flow	-$12.1Mn/m	-$27.3Mn/m	-$18.8M-159.8%	-$10.2Mn/m	-$7.0M-221.1%	-$13.1Mn/m	$31.5M+341.5%	-$3.2Mn/m
Financing Cash Flow	$14.3Mn/m	-$626K-103.2%	$33.1M-4.9%	$72.2M+13898.8%	-$2.7Mn/m	$19.5Mn/m	$34.8Mn/m	$516Kn/m
Share Buybacks	N/A	N/A	$0n/m	$4.9Mn/m	N/A	N/A	$0n/m	$0n/m

Not reported in any period shown, so not listed: Dividends Paid.

BBBY Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BBBY quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	24.6%+3.9pp	20.8%-2.6pp	23.4%-2.9pp	26.3%+3.7pp	22.6%-0.3pp	22.9%+2.8pp	20.1%+0.6pp	19.4%-0.1pp	19.5%+1.1pp	18.4%0.0pp	18.4%-0.3pp	18.6%-0.4pp	19.0%+0.9pp	18.1%+1.1pp	17.0%
Operating Margin	-5.9%+7.3pp	-13.2%-4.0pp	-9.2%-10.6pp	1.4%-2.6pp	4.0%+0.2pp	3.9%+8.2pp	-4.3%+7.6pp	-11.9%-9.3pp	-2.7%-3.1pp	0.4%+0.4pp	0.0%-0.8pp	0.8%-0.5pp	1.3%+0.2pp	1.1%+2.8pp	-1.7%
Net Margin	-8.1%+10.4pp	-18.6%+1.2pp	-19.7%-17.9pp	-1.8%-16.0pp	14.1%+11.9pp	2.3%+10.7pp	-8.5%+2.8pp	-11.3%-5.0pp	-6.3%-7.0pp	0.7%+0.5pp	0.1%-0.4pp	0.6%-5.9pp	6.5%+5.1pp	1.3%+3.2pp	-1.8%
Return on Equity	-38.9%+120.1pp	-159.0%-73.3pp	-85.7%-80.3pp	-5.5%-57.8pp	52.3%+37.3pp	15.0%+120.9pp	-105.9%+50.5pp	-156.4%-93.8pp	-62.6%-69.7pp	7.1%+5.5pp	1.6%-5.2pp	6.9%-64.2pp	71.0%+23.7pp	47.4%+194.2pp	-146.8%
Return on Assets	-19.9%+44.5pp	-64.4%-16.0pp	-48.4%-44.4pp	-4.0%-40.5pp	36.5%+29.8pp	6.8%+35.9pp	-29.2%+15.5pp	-44.7%-19.3pp	-25.3%-27.9pp	2.6%+2.0pp	0.6%-1.8pp	2.4%-24.4pp	26.7%+18.7pp	8.1%+18.9pp	-10.8%
Current Ratio	1.25+0.2x	1.01-0.5x	1.51-0.7x	2.17+0.1x	2.03+0.2x	1.78+1.0x	0.82-0.1x	0.89-0.3x	1.24+0.3x	0.980.0x	0.96-0.1x	1.06-0.1x	1.13+0.1x	1.05+0.1x	0.91
Debt-to-Equity	0.00	N/A	N/A	0.050.0x	0.05-0.1x	0.11+0.1x	0.000.0x	0.020.0x	0.00-0.3x	0.25+0.2x	0.06+0.1x	0.00	N/A	N/A	N/A
Liabilities-to-Equity	0.95-0.5x	1.47+0.7x	0.77+0.4x	0.36-0.1x	0.43-0.6x	1.05-1.0x	2.08+0.2x	1.90+0.4x	1.49-0.3x	1.78-0.1x	1.85-0.1x	1.92+0.3x	1.66-3.2x	4.88-7.7x	12.56
Asset Turnover	2.46-1.0x	3.47+1.0x	2.46+0.3x	2.20-0.4x	2.59-0.4x	3.00-0.4x	3.44-0.5x	3.95-0.1x	4.02+0.3x	3.71-0.2x	3.87-0.1x	3.97-0.2x	4.13-1.9x	6.04+0.2x	5.87
FCF Margin	-6.1%+7.4pp	-13.5%-11.1pp	-2.4%-1.0pp	-1.4%-3.9pp	2.4%-4.8pp	7.3%+13.9pp	-6.6%+2.6pp	-9.2%-5.8pp	-3.4%-1.6pp	-1.8%-1.5pp	-0.3%-2.9pp	2.6%-2.4pp	5.0%+3.6pp	1.4%-0.2pp	1.6%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	26.8%+3.0pp	23.9%-1.2pp	24.6%+1.6pp	25.3%+4.2pp	23.7%+3.6pp	25.1%+5.6pp	23.0%+3.8pp	21.2%-1.0pp
Operating Margin	-11.9%-7.5pp	-7.3%+2.7pp	-4.8%+6.5pp	-4.8%+9.7pp	-4.4%+7.4pp	-10.0%+5.0pp	-11.3%+12.2pp	-14.5%-3.6pp
Net Margin	-10.9%-4.1pp	-6.6%+10.6pp	-7.6%+19.2pp	-1.8%+17.8pp	-6.8%+3.9pp	-17.2%+2.1pp	-26.8%+15.1pp	-19.6%-2.7pp
Return on Equity	-18.4%-3.6pp	-8.1%+19.7pp	-9.6%+40.3pp	-2.2%+28.9pp	-14.8%+2.2pp	-27.8%-2.1pp	-49.9%-5.1pp	-31.1%-18.9pp
Return on Assets	-6.2%-0.8pp	-4.0%+6.9pp	-4.9%+15.3pp	-1.1%+13.2pp	-5.4%+3.2pp	-11.0%+1.8pp	-20.2%+5.1pp	-14.2%-6.1pp
Current Ratio	0.76-0.1x	1.03+0.1x	1.25+0.2x	1.17+0.2x	0.91-0.2x	0.95-0.3x	1.01-0.5x	0.97-0.8x
Debt-to-Equity	0.06	N/A	0.00	N/A	N/A	N/A	N/A	N/A
Liabilities-to-Equity	1.95+0.2x	1.00-0.5x	0.95-0.5x	1.04-0.1x	1.73+0.7x	1.54+0.5x	1.47+0.7x	1.18+0.7x
Asset Turnover	0.57-0.2x	0.610.0x	0.64-0.1x	0.62-0.1x	0.790.0x	0.640.0x	0.75+0.1x	0.73+0.2x
FCF Margin	-11.6%-16.6pp	-5.2%+17.3pp	-3.2%+5.0pp	-6.8%+7.9pp	5.0%+25.2pp	-22.5%-12.5pp	-8.1%-0.2pp	-14.6%-10.8pp

Where Bed Bath & Beyond, Inc. Ranks

Frequently Asked Questions

What is Bed Bath & Beyond, Inc.'s annual revenue?

Bed Bath & Beyond, Inc. (BBBY) reported $1.0B in total revenue for fiscal year 2025. This represents a -25.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Bed Bath & Beyond, Inc.'s revenue growing?

Bed Bath & Beyond, Inc. (BBBY) revenue declined by 25.1% year-over-year, from $1.4B to $1.0B in fiscal year 2025.

Is Bed Bath & Beyond, Inc. profitable?

No, Bed Bath & Beyond, Inc. (BBBY) reported a net loss of $81.3M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net loss of $84.6M, with a net profit margin of -8.1%.

What is Bed Bath & Beyond, Inc.'s EBITDA?

Bed Bath & Beyond, Inc. (BBBY) had EBITDA of -$44.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Bed Bath & Beyond, Inc. have?

As of fiscal year 2025, Bed Bath & Beyond, Inc. (BBBY) had $175.3M in cash and equivalents against $0 in long-term debt.

What is Bed Bath & Beyond, Inc.'s gross margin?

Bed Bath & Beyond, Inc. (BBBY) had a gross margin of 24.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Bed Bath & Beyond, Inc.'s operating margin?

Bed Bath & Beyond, Inc. (BBBY) had an operating margin of -5.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Bed Bath & Beyond, Inc.'s net profit margin?

Bed Bath & Beyond, Inc. (BBBY) had a net profit margin of -8.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Bed Bath & Beyond, Inc.'s return on equity (ROE)?

Bed Bath & Beyond, Inc. (BBBY) has a return on equity of -38.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Bed Bath & Beyond, Inc.'s free cash flow?

Bed Bath & Beyond, Inc. (BBBY) recorded an outflow of $64.1M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Bed Bath & Beyond, Inc.'s operating cash flow?

Bed Bath & Beyond, Inc. (BBBY) recorded an outflow of $56.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Bed Bath & Beyond, Inc.'s total assets?

Bed Bath & Beyond, Inc. (BBBY) had $425.5M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Bed Bath & Beyond, Inc.'s capital expenditures?

Bed Bath & Beyond, Inc. (BBBY) invested $7.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Bed Bath & Beyond, Inc. buy back shares?

Yes, Bed Bath & Beyond, Inc. (BBBY) spent $6.2M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Bed Bath & Beyond, Inc. have outstanding?

Bed Bath & Beyond, Inc. (BBBY) had 69M shares outstanding as of fiscal year 2025.

What is Bed Bath & Beyond, Inc.'s current ratio?

Bed Bath & Beyond, Inc. (BBBY) had a current ratio of 1.25 as of fiscal year 2025, which is considered adequate.

What is Bed Bath & Beyond, Inc.'s debt-to-equity ratio?

Bed Bath & Beyond, Inc. (BBBY) had a debt-to-equity ratio of 0.00 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

What is Bed Bath & Beyond, Inc.'s liabilities-to-equity ratio?

Bed Bath & Beyond, Inc. (BBBY) had a liabilities-to-equity ratio of 0.95 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

What is Bed Bath & Beyond, Inc.'s return on assets (ROA)?

Bed Bath & Beyond, Inc. (BBBY) had a return on assets of -19.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

How does Bed Bath & Beyond, Inc.'s liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, Bed Bath & Beyond, Inc. (BBBY) held $241.9M in cash, cash equivalents and investments, and reported an operating cash outflow of $56.7M over that year. Dividing the one by the other, the reported balance equals about 51 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Bed Bath & Beyond, Inc.'s Piotroski F-Score?

Bed Bath & Beyond, Inc. (BBBY) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Bed Bath & Beyond, Inc.'s earnings high quality?

Bed Bath & Beyond, Inc. (BBBY) reported a net loss of $84.6M while operations used $56.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Bed Bath & Beyond, Inc. cover its interest payments?

Bed Bath & Beyond, Inc. (BBBY) reported an operating loss of $61.2M against $1.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Bed Bath & Beyond, Inc.?

Bed Bath & Beyond, Inc. (BBBY) scores 29 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.